← Oncology Approval Tracker

FDA DECISION ·

Tepylute

thiotepa · Shorla Oncology

FDA approvalNew formulationBreast and ovarian cancers
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Thiotepa injection for treatment of adenocarcinoma of the breast or ovary.

LAMPGEN ANALYSIS

Why it matters

The ready-to-dilute thiotepa solution changes preparation for a long-established oncology drug.

What research teams should watch

Match the indication and concentration to the specific product and use hazardous-drug handling and marrow monitoring procedures.

PRIMARY RECORDS

Sources